|
1
|
Chang DD, Park NH, Denny CT, Nelson SF and
Pe M: Characterization of transformation related genes in oral
cancer cells. Oncogene. 16:1921–1930. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Song Y, Maul RS, Gerbin CS and Chang DD:
Inhibition of anchorage-independent growth of transformed NIH3T3
cells by epithelial protein lost in neoplasm (EPLIN) requires
localization of EPLIN to actin cytoskeleton. Mol Biol Cell.
13:1408–1416. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maul RS, Song Y, Amann KJ, Gerbin SC,
Pollard TD and Chang DD: EPLIN regulates actin dynamics by
cross-linking and stabilizing filaments. J Cell Biol. 160:399–407.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Abe K and Takeichi M: EPLIN mediates
linkage of the cadherin catenin complex to F-actin and stabilizes
the circumferential actin belt. Proc Natl Acad Sci USA. 105:13–19.
2008. View Article : Google Scholar
|
|
5
|
Maul RS and Chang DD: EPLIN, epithelial
protein lost in neoplasm. Oncogene. 18:7838–7841. 1999. View Article : Google Scholar
|
|
6
|
Chen S, Maul RS, Kim HR and Chang DD:
Characterization of the human EPLIN (epithelial protein lost in
neoplasm) gene reveals distinct promoters for the two EPLIN
isoforms. Gene. 248:69–76. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang WG, Martin TA, Lewis-Russell JM,
Douglas-Jones A, Ye L and Mansel RE: Eplin-alpha expression in
human breast cancer, the impact on cellular migration and clinical
outcome. Mol Cancer. 7:71–80. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sanders AJ, Martin TA, Ye L, Mason MD and
Jiang WG: EPLIN is a negative regulator of prostate cancer growth
and invasion. J Urol. 186:295–301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang S, Wang X, Osunkoya AO, Iqbal S,
Wang Y, Chen Z, Müller S, Chen Z, Josson S, Coleman IM, et al:
EPLIN downregulation promotes epithelial-mesenchymal transition in
prostate cancer cells and correlates with clinical lymph node
metastasis. Oncogene. 30:4941–4952. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Han MY, Kosako H, Watanabe T and Hattori
S: Extracellular signal-regulated kinase/mitogen-activated protein
kinase regulates actin organization and cell motility by
phosphorylating the actin cross-linking protein EPLIN. Mol Cell
Biol. 27:8190–8204. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Seong BKA, Lau J, Adderley T, Kee L,
Chaukos D, Pienkowska M, Malkin D, Thorner P and Irwin MS: SATB2
enhances migration and invasion in osteosarcoma by regulating genes
involved in cytoskeletal organization. Oncogene. 34:3582–3592.
2015. View Article : Google Scholar
|
|
12
|
Steder M, Alla V, Meier C, Spitschak A,
Pahnke J, Fürst K, Kowtharapu BS, Engelmann D, Petigk J, Egberts F,
et al: DNp73 exerts function in metastasis initiation by
disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3
signaling. Cancer Cell. 24:512–527. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang WG, Watkins G, Douglas-Jones A,
Mokbel K, Mansel RE and Fodstad O: Expression of Com-1/P8 in human
breast cancer and its relevance to clinical outcome and ER status.
Int J Cancer. 117:730–737. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang WG, Davies G and Fodstad O: Com-1/P8
in oestrogen regulated growth of breast cancer cells, the ER-beta
connection. Biochem Biophys Res Commun. 330:253–262. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang WG, Davies G, Martin TA, Kynaston H,
Mason MD and Fodstad O: Com-1/p8 acts as a putative tumour
suppressor in prostate cancer. Int J Mol Med. 18:981–986.
2006.PubMed/NCBI
|
|
16
|
Jiang WG, Davies G, Martin TA, Parr C,
Watkins G, Mason MD and Mansel RE: Expression of membrane type-1
matrix metalloproteinase, MT1-MMP in human breast cancer and its
impact on invasiveness of breast cancer cells. Int J Mol Med.
17:583–590. 2006.PubMed/NCBI
|
|
17
|
Jiang WG, Davies G, Martin TA, Parr C,
Watkins G, Mason MD, Mokbel K and Mansel RE: Targeting matrilysin
and its impact on tumor growth in vivo: The potential implications
in breast cancer therapy. Clin Cancer Res. 11:6012–6019. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang WG, Hiscox S, Singhrao SK, Nakamura
T, Puntis MC and Hallett MB: Inhibition of HGF/SF-induced membrane
ruffling and cell motility by transient elevation of cytosolic free
Ca2+. Exp Cell Res. 220:424–433. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang WG, Hiscox S, Hallett MB, Horrobin
DF, Scott C and Puntis MCA: Inhibition of invasion and motility of
human colon cancer cells by gamma linolenic acid. Br J Cancer.
71:744–752. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Y, Sanders AJ, Zhang L and Jiang WG:
EPLIN-Alpha expression in human oesophageal cancer and its impact
on cellular aggressiveness and clinical outcome. Anticancer Res.
32:1283–1289. 2012.PubMed/NCBI
|
|
21
|
Sanders AJ, Ye L, Mason MD and Jiang WG:
The impact of EPLINα (Epithelial protein lost in neoplasm) on
endothelial cells, angiogenesis and tumorigenesis. Angiogenesis.
13:317–326. 2010. View Article : Google Scholar : PubMed/NCBI
|
